|
FASTKD2 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.75309997022077E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
9.753400E-01 |
| Stage1-vs-Stage3 |
1.748200E-01 |
| Stage1-vs-Stage4 |
1.059520E-03 |
| Stage2-vs-Stage3 |
4.009200E-01 |
| Stage2-vs-Stage4 |
5.270000E-02 |
| Stage3-vs-Stage4 |
1.060430E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
3.71030000001493E-06 |
| Normal-vs-Asian |
2.88440382689714E-11 |
| Caucasian-vs-AfricanAmerican |
2.135400E-01 |
| Caucasian-vs-Asian |
7.316400E-01 |
| AfricanAmerican-vs-Asian |
3.610200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.88178419700125E-16 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
9.530600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.55595544729204E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63236091310637E-12 |
| Normal-vs-Age(81-100Yrs) |
9.400600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.447200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.624000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.385000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.766600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.724400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.779400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.308400E-02 |
| Classical-VS-Follicular |
2.947400E-01 |
| Classical-VS-Other |
1.851810E-01 |
| Classical-VS-Normal |
1.26170185410501E-11 |
| Tall-VS-Follicular |
1.898550E-01 |
| Tall-VS-Other |
8.718000E-01 |
| Tall-VS-Normal |
8.83293438391775E-13 |
| Follicular-VS-Other |
4.824600E-01 |
| Follicular-VS-Normal |
4.37483382853543E-12 |
| Other-VS-Normal |
1.176360E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
6.20614670765463E-14 |
| N0-vs-N1 |
1.108390E-01 |
|
|
